Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (157) 157
index medicus (113) 113
male (103) 103
female (102) 102
microbiology (99) 99
infectious diseases (93) 93
middle aged (93) 93
aged (88) 88
adult (68) 68
mortality (55) 55
risk factors (55) 55
prospective studies (49) 49
anti-bacterial agents - therapeutic use (45) 45
pharmacology & pharmacy (45) 45
bacteremia (42) 42
aged, 80 and over (41) 41
treatment outcome (41) 41
infective endocarditis (40) 40
epidemiology (38) 38
diagnosis (37) 37
prognosis (36) 36
spain - epidemiology (35) 35
management (34) 34
infections (33) 33
microbial sensitivity tests (32) 32
endocarditis (30) 30
retrospective studies (28) 28
spain (28) 28
therapy (28) 28
risk-factors (27) 27
bacteremia - microbiology (26) 26
cohort studies (26) 26
infectious disease (26) 26
bacteremia - drug therapy (23) 23
health aspects (23) 23
immunology (23) 23
antibiotics (22) 22
hospitals (22) 22
adolescent (21) 21
staphylococcus aureus (21) 21
antifungal agents - therapeutic use (20) 20
research (20) 20
surgery (19) 19
blood-stream infections (18) 18
cross infection - epidemiology (18) 18
drug therapy (18) 18
endocarditis, bacterial - microbiology (18) 18
comorbidity (17) 17
endocarditis, bacterial - drug therapy (16) 16
staphylococcal infections - drug therapy (16) 16
anti-bacterial agents - pharmacology (15) 15
cross infection - microbiology (15) 15
nosocomial infections (15) 15
analysis (14) 14
bacteremia - mortality (14) 14
hospital mortality (14) 14
incidence (14) 14
patients (14) 14
abridged index medicus (13) 13
animals (13) 13
bacteria (13) 13
care and treatment (13) 13
cross infection - drug therapy (13) 13
endocarditis - mortality (13) 13
guidelines (13) 13
internal medicine (13) 13
medicine, general & internal (13) 13
staphylococcal infections - microbiology (13) 13
survival analysis (13) 13
bacteremia - epidemiology (12) 12
candida - isolation & purification (12) 12
endocarditis, bacterial - epidemiology (12) 12
follow-up studies (12) 12
patient outcomes (12) 12
prevalence (12) 12
regression analysis (12) 12
young adult (12) 12
anti-bacterial agents - administration & dosage (11) 11
cardiac & cardiovascular systems (11) 11
complications (11) 11
cross infection (11) 11
fluconazole (11) 11
life sciences (11) 11
outcomes (11) 11
prevention (11) 11
staphylococcal infections - epidemiology (11) 11
bacterial infections and mycoses (10) 10
cross infection - mortality (10) 10
endocarditis - drug therapy (10) 10
endocarditis - microbiology (10) 10
gram-positive bacterial infections - drug therapy (10) 10
methicillin-resistant staphylococcus aureus - isolation & purification (10) 10
multivariate analysis (10) 10
population surveillance (10) 10
staphylococcal infections - mortality (10) 10
vancomycin (10) 10
aids (9) 9
anti-infective agents - therapeutic use (9) 9
antifungal agents - pharmacology (9) 9
antimicrobial resistance (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
by Gutiérrez-Gutiérrez, Belén, PhD and Salamanca, Elena, MD and de Cueto, Marina, PhD and Hsueh, Po-Ren, MD and Viale, Pierluigi, Prof and Paño-Pardo, José Ramón, PhD and Venditti, Mario, MD and Tumbarello, Mario, MD and Daikos, George, PhD and Cantón, Rafael, PhD and Doi, Yohei, PhD and Tuon, Felipe Francisco, PhD and Karaiskos, Ilias, PhD and Pérez-Nadales, Elena, PhD and Schwaber, Mitchell J, MD and Azap, Özlem Kurt, PhD and Souli, Maria, PhD and Roilides, Emmanuel, PhD and Pournaras, Spyros, MD and Akova, Murat, MD and Pérez, Federico, MD and Bermejo, Joaquín, MD and Oliver, Antonio, PhD and Almela, Manel, PhD and Lowman, Warren, MMed and Almirante, Benito, PhD and Bonomo, Robert A, MD and Carmeli, Yehuda, PhD and Paterson, David L, PhD and Pascual, Alvaro, Prof and Rodríguez-Baño, Jesús, Dr and REIPI ESGBIS INCREMENT and REIPI/ESGBIS/INCREMENT Investigators
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 726 - 734
Summary Background The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is unknown. The objective of this study was to... 
Infectious Disease | INFECTIOUS DISEASES | K.-PNEUMONIAE | REGIMENS | PREDICTORS | BACTEREMIA | KLEBSIELLA-PNEUMONIAE | Klebsiella Infections - drug therapy | Klebsiella pneumoniae - drug effects | Humans | Risk Factors | Bacteremia - drug therapy | Bacteremia - mortality | Male | Bacterial Proteins | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Propensity Score | Drug Therapy, Combination - methods | beta-Lactamases | Female | Klebsiella Infections - mortality | Aged | Retrospective Studies | Mortality | Analysis | Therapy | Pneumonia | Adjustment | Laboratories | Funding | Carbapenemase | Regional development | Cultures | Infections | Regression analysis | Multivariate analysis | Epidemiology | Patients | Survival | Standards | Blood | Diseases | Studies | Infectious diseases | Hospitals | Antibiotics | Death
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Management of infections related to totally implantable venous-access ports: challenges and perspectives
by Lebeaux, David, MD and Fernández-Hidalgo, Nuria, MD and Chauhan, Ashwini, PhD and Lee, Samuel, MD and Ghigo, Jean-Marc, PhD and Almirante, Benito, Dr and Beloin, Christophe, Dr
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 2, pp. 146 - 159
Summary Use of totally implantable venous-access ports (TIVAPs) is standard practice for patients with diseases such as solid-tumour cancers, haematological... 
Infectious Disease | CLINICAL-PRACTICE GUIDELINES | ANTIBIOTIC-LOCK | INFECTIOUS DISEASES | CATHETER-RELATED BACTEREMIA | LONG-TERM USE | CANCER-PATIENTS | ETHANOL LOCK THERAPY | HOME-PARENTERAL-NUTRITION | STAPHYLOCOCCUS-AUREUS BACTEREMIA | TAUROLIDINE-CITRATE | BLOOD-STREAM INFECTIONS | Device Removal | Catheter-Related Infections - etiology | Humans | Risk Factors | Catheterization, Central Venous - methods | Bacteremia - diagnosis | Catheter-Related Infections - therapy | Candidemia - diagnosis | Anti-Bacterial Agents - therapeutic use | Candidemia - therapy | Bacteremia - therapy | Catheters, Indwelling - adverse effects | Bacteremia - etiology | Catheter-Related Infections - diagnosis | Catheterization, Central Venous - instrumentation | Candidemia - etiology | Implants, Artificial | Prosthesis | Health aspects | Medical care, Cost of | Microorganisms | Chemotherapy | Hematology | Nutrition | Parenteral nutrition | Bacteria | Infections | Skin | Catheters | Risk factors | Catheter-Related Infections/etiology | Bacteremia/etiology | Bacteremia/therapy | Catheter-Related Infections/diagnosis | Catheters, Indwelling/adverse effects | Candidemia/etiology | Catheter-Related Infections/therapy | Catheterization, Central Venous/methods | Bacteriology | Bacteremia/diagnosis | Life Sciences | Candidemia/diagnosis | Microbiology and Parasitology | Candidemia/therapy | Catheterization, Central Venous/instrumentation | Anti-Bacterial Agents/therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Reply to Octaria, Rebeiro, and Kainer
by Willekens, Rein and Martin-Castillo, Mario and Almirante, Benito
Clinical Infectious Diseases, ISSN 1058-4838, 10/2019, Volume 69, Issue 9, pp. 1645 - 1645
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients
by Cuervo, Guillermo and Camoez, Mariana and Shaw, Evelyn and Dominguez, María Ángeles and Gasch, Oriol and Padilla, Belén and Pintado, Vicente and Almirante, Benito and Molina, José and López-Medrano, Francisco and De Gopegui, Enrique Ruiz and Martinez, José A and Bereciartua, Elena and Rodriguez-Lopez, Fernando and Fernandez-Mazarrasa, Carlos and Goenaga, Miguel Ángel and Benito, Natividad and Rodríguez-Baño, Jesús and Espejo, Elena and Pujol, Miquel and Jover, A and Barcenilla, F and Garcia, M and Ojeda, E and Marco, F and Chaves, F and Lagarde, M and Montejo, J.M and Hernández, J.L and Von Wichmann, M.A and García-Arenzana, J.M and Padilla, C and Cercenado, E and García-Pardo, G and Tapiol, J and Horcajada, J.P and Montero, M and Salvado, M and Arnáiz, A and Fernandez, C and Calbo, E and Xercavins, M and Granados, A and Fontanals, D and Loza, E and Torre-Cisneros, J and Lara, R and Rodríguez, M and Natera, C and Blanco, J.R and Olarte, I and Mirelis, B and Murillas, J and López, E and Pascual, A and Martín, C and Lepe, J.A and Sordé, R and Larrosa, N and Morera, M.A and REIPI GEIH Study Grp and REIPI/GEIH Study Group and On behalf of the REIPI/GEIH study group
BMC Infectious Diseases, ISSN 1471-2334, 10/2015, Volume 15, Issue 1, p. 484
Background: The aim of the study was to determine clinical and microbiological differences between patients with methicillin-resistant Staphylococcus aureus... 
Bacteraemia | Haemodialysis | Catheter-related | MRSA | INFECTIOUS DISEASES | BLOOD-STREAM INFECTION | RISK-FACTORS | DISEASES SOCIETY | CLINICAL-PRACTICE GUIDELINES | GRAM-NEGATIVE BACTEREMIA | VANCOMYCIN | MINIMUM INHIBITORY CONCENTRATION | OUTCOMES | NASAL CARRIAGE | FIELD GEL-ELECTROPHORESIS | Prospective Studies | Humans | Middle Aged | Male | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Female | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Methicillin-Resistant Staphylococcus aureus - genetics | Cross Infection - epidemiology | Staphylococcal Infections - drug therapy | Comorbidity | Bacteremia - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Spain | Staphylococcal Infections - epidemiology | Vancomycin - therapeutic use | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Aged | Renal Dialysis | Complications and side effects | Care and treatment | Catheterization | Hemodialysis | Physiological aspects | Research | Health aspects | Staphylococcus aureus | Bacteremia | Infectious diseases | Estafilococs | Bacteria | Bacteris | Hemodiàlisi | Staphylococcus | Cateterisme
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Experiencia clínica del uso de daptomicina en España. Resultados globales del registro EUCORE
by Almirante, Benito
Medicina Clinica, ISSN 0025-7753, 12/2010, Volume 135, Issue 3, pp. 23 - 28
The European Cubicin® Outcome Registry and Experience (EU-CORE) is a retrospective, non-interventional, multicenter database of daptomycin use in several... 
Daptomycin | Osteoarticular infections | Infective endocarditis | Bacteremia | Gram-positive infections
Journal Article
Details down arrow
6. Full Text Predictive factors for early mortality among patients with methicillin-resistant staphylococcus aureus bacteraemia
by Gasch, O and Camoez, M and Domínguez, M. A and Padilla, B and Pintado, V and Almirante, B and Lepe, J. A and Lagarde, M and de Gopegui, E. Ruiz and Martínez, J. A and Montejo, M and Torre-Cisneros, J and Arná iz, A and Goenaga, M. A and N. Benito, Benito and Rodríguez-Bano, J and Pujol, M and GEIH Study Grp and REIPI Study Grp and REIPI/GEIH Study Groups and on behalf of the REIPI/GEIH Study Groups
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 06/2013, Volume 68, Issue 6, pp. 1423 - 1430
A high proportion of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia die within a few days of the onset of infection. However,... 
Bloodstream infections | Empirical antibiotic therapy | MRSA | empirical antibiotic therapy | INFECTIOUS DISEASES | RISK-FACTORS | MICROBIOLOGY | ANTIBIOTIC-THERAPY | bloodstream infections | IMPACT | VANCOMYCIN | MINIMUM INHIBITORY CONCENTRATION | HOSPITAL ADMISSION | PHARMACOLOGY & PHARMACY | OUTCOMES | BLOOD-STREAM INFECTIONS | FIELD GEL-ELECTROPHORESIS | METICILLIN RESISTANCE | Predictive Value of Tests | Age Factors | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Middle Aged | Risk Factors | Drug Resistance, Bacterial | Bacteremia - mortality | Logistic Models | Male | Treatment Outcome | Bacteremia - microbiology | Microbial Sensitivity Tests | Staphylococcal Infections - mortality | Sex Factors | Female | Aged | Staphylococcal Infections - microbiology | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text The authors reply
by Almirante, Benito and Puig-Asensio, Mireia
Critical Care Medicine, ISSN 0090-3493, 09/2014, Volume 42, Issue 9, pp. e629 - e630
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The authors reply
by Almirante, Benito and Puig-Asensio, Mireia
Critical Care Medicine, ISSN 0090-3493, 09/2014, Volume 42, Issue 9, pp. e629 - e630
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model
by Basas, Jana and Palau, Marta and Gomis, Xavier and Almirante, Benito and Gavaldà, Joan
PLoS ONE, ISSN 1932-6203, 02/2019, Volume 14, Issue 2, p. e0212426
The aims of this study were as follows. First, we sought to compare the in vitro susceptibility of liposomal amphotericin B (LAmB) and anidulafungin on Candida... 
Candida albicans | Research | Amphotericin B | Drug therapy | Health aspects | Antifungal agents | Yeasts | Rabbits | Fungicides | Laboratories | Medical instruments | Confocal microscopy | Infections | Drug resistance | Catheters | Infectious diseases | Biofilms | Antibiotics | Microscopy | Morphology | Silicones | Viability
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli : Risk Factors and Prognosis
by Jesús Rodríguez-Baño and Encarnación Picón and Paloma Gijón and José Ramón Hernández and Maite Ruíz and Carmen Peña and Manuel Almela and Benito Almirante and Fabio Grill and Javier Colomina and Monserrat Giménez and Antonio Oliver and Juan Pablo Horcajada and Gemma Navarro and Ana Coloma and Alvaro Pascual and Spanish Network Res Infect Dis REI and Spanish Network for Research in Infectious Diseases (REIPI)
Clinical Infectious Diseases, ISSN 1058-4838, 1/2010, Volume 50, Issue 1, pp. 40 - 48
Background. There is little clinical information about community-onset bloodstream infections (COBSIs) caused by extended-spectrum β-lactamase (ESBL)-producing... 
Control groups | Cephalosporins | Antimicrobials | Escherichia coli | Mortality | Predisposing factors | Sepsis | Infections | ARTICLES AND COMMENTARIES | Epidemiology | Bacteremia | INFECTIOUS DISEASES | GUIDELINES | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | CTX-M | FECAL CARRIAGE | NATIONWIDE | MOLECULAR EPIDEMIOLOGY | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Multivariate Analysis | beta-Lactam Resistance | Prognosis | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Middle Aged | Male | beta-Lactamases - biosynthesis | Case-Control Studies | Bacteremia - microbiology | Microbial Sensitivity Tests | Adult | Female | Escherichia coli - enzymology | Risk Factors | Escherichia coli Infections - microbiology | Logistic Models | Escherichia coli Infections - epidemiology | Escherichia coli - isolation & purification | Spain - epidemiology | Adolescent | Bacteremia - epidemiology | Aged | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - microbiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The authors reply
by Almirante, Benito and Puig-Asensio, Mireia
Critical Care Medicine, ISSN 0090-3493, 2014, Volume 42, Issue 9, pp. e629 - e630
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
by Gutiérrez-Gutiérrez, Belén, MD, PhD and Salamanca, Elena, MD and de Cueto, Marina, MD, PhD and Hsueh, Po-Ren, MD and Viale, Pierluigi, MD and Paño-Pardo, José Ramón, MD, PhD and Venditti, Mario, MD, PhD and Tumbarello, Mario, MD and Daikos, George, MD, PhD and Pintado, Vicente, MD and Doi, Yohei, MD, PhD and Tuon, Felipe Francisco, MD, PhD and Karaiskos, Ilias, MD, PhD and Machuca, Isabel, MD and Schwaber, Mitchell J., MD and Azap, Özlem Kurt, MD, PhD and Souli, Maria, MD, PhD and Roilides, Emmanuel, MD, PhD and Pournaras, Spyros, MD and Akova, Murat, MD and Pérez, Federico, MD and Bermejo, Joaquín, MD and Oliver, Antonio, MD, PhD and Almela, Manel, MD, PhD and Lowman, Warren, MMed and Almirante, Benito, MD, PhD and Bonomo, Robert A., MD and Carmeli, Yehuda, MD, PhD and Paterson, David L., MD, PhD and Pascual, Alvaro, MD, PhD and Rodríguez-Baño, Jesús, MD, PhD and REIPI ESGBIS INCREMENT Grp and Investigators from the REIPI/ESGBIS/INCREMENT Group
Mayo Clinic Proceedings, ISSN 0025-6196, 2016, Volume 91, Issue 10, pp. 1362 - 1371
Abstract Objective To develop a score to predict mortality in patients with bloodstream infections (BSIs) due to carbapenemase-producing Enterobacteriaceae... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | THERAPY | BETA-LACTAMASE | BACTEREMIA | RESISTANCE | OUTCOMES | K.-PNEUMONIAE | KLEBSIELLA-PNEUMONIAE INFECTION | Predictive Value of Tests | Comorbidity | Humans | Middle Aged | Bacteremia - drug therapy | Decision Support Techniques | Enterobacteriaceae Infections - mortality | Bacteremia - mortality | Logistic Models | Male | Enterobacteriaceae - metabolism | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Sensitivity and Specificity | Bacterial Proteins - metabolism | Female | Aged | Retrospective Studies | beta-Lactamases - metabolism | Enterobacteriaceae Infections - drug therapy | Greece | Klebsiella infections | Enterobacter | Mortality | Analysis | Physiological aspects | Research | Risk factors | Spain | Enterobacteriaceae
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis
by Nuria Fernández-Hidalgo and Benito Almirante and Joan Gavaldà and Mercè Gurgui and Carmen Peña and Arístides de Alarcón and Josefa Ruiz and Isidre Vilacosta and Miguel Montejo and Nuria Vallejo and Francisco López-Medrano and Antonio Plata and Javier López and Carmen Hidalgo-Tenorio and Juan Gálvez and Carmen Sáez and José Manuel Lomas and Marco Falcone and Javier de la Torre and Xavier Martínez-Lacasa and Albert Pahissa
Clinical Infectious Diseases, ISSN 1058-4838, 5/2013, Volume 56, Issue 9, pp. 1261 - 1268
Background. The aim of this study was to compare the effectiveness of the ampicillin plus ceftriaxone (AC) and ampicillin plus gentamicin (AG) combinations for... 
Enterococcus faecalis | Health outcomes | Relapse | Kidney failure | Infectious diseases | Antimicrobials | Endocarditis | Aminoglycosides | Infections | ARTICLES AND COMMENTARIES | Heart valves | gentamicin | ampicillin plus ceftriaxone | infective endocarditis | outcome | DIAGNOSIS | INFECTIOUS DISEASES | AMINOGLYCOSIDES | MANAGEMENT | EFFICACY | PROGNOSIS | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | RESISTANT | THERAPY | ASSOCIATION | Enterococcus faecalis - drug effects | Humans | Middle Aged | Male | Ampicillin - administration & dosage | Gentamicins - administration & dosage | Young Adult | Endocarditis - microbiology | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Adult | Ceftriaxone - administration & dosage | Female | Treatment Outcome | Spain | Enterococcus faecalis - isolation & purification | Drug Therapy, Combination - methods | Hospitals | Adolescent | Italy | Aged | Endocarditis - drug therapy | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Cohort Studies | Drugs | Dose-response relationship (Biochemistry) | Ampicillin | Gentamicin | Infective endocarditis | Ceftriaxone sodium | Dosage and administration | Product/Service Evaluations | Ceftriaxone | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort
by Carmen Peña and Cristina Suarez and Alain Ocampo-Sosa and Javier Murillas and Benito Almirante and Virginia Pomar and Manuela Aguilar and Ana Granados and Esther Calbo and Jesús Rodríguez-Baño and Fernando Rodríguez and Fe Tubau and Antonio Oliver and Luis Martínez-Martínez and Spanish Network Res Infect Dis and Spanish Network for Research in Infectious Diseases (REIPI) and for the Spanish Network for Research in Infectious Diseases (REIPI)
Clinical Infectious Diseases, ISSN 1058-4838, 7/2013, Volume 57, Issue 2, pp. 208 - 216
Background. Empirical combination therapy is recommended for patients with known or suspected Pseudomonas aeruginosa (PA) infection as a means to decrease the... 
Health outcomes | Antibiotics | Antimicrobials | Mortality | Pseudomonas aeruginosa | Sepsis | Infections | ARTICLES AND COMMENTARIES | Bacteremia | Disease risks | Empirical adequacy | bloodstream infections | mortality | combination antimicrobial therapy | P. aeruginosa | INFECTIOUS DISEASES | MANAGEMENT | VENTILATOR-ASSOCIATED PNEUMONIA | MICROBIOLOGY | BETA-LACTAM MONOTHERAPY | IMMUNOLOGY | ANTIBIOTIC-THERAPY | BENEFIT | AMINOGLYCOSIDE | MORBIDITY | BACTEREMIA | SEPTIC SHOCK | SEVERE SEPSIS | Prospective Studies | Pseudomonas Infections - drug therapy | Humans | Middle Aged | Bacteremia - drug therapy | Bacteremia - mortality | Male | Treatment Outcome | Pseudomonas Infections - mortality | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Cohort Studies | Blood-borne diseases | Usage | Patient outcomes | Anti-infective agents | Drug therapy, Combination | Drug therapy | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Antibiotic-lock therapy: a clinical viewpoint
by Fernández-Hidalgo, Nuria and Almirante, Benito
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 01/2014, Volume 12, Issue 1, pp. 117 - 129
Antibiotic lock therapy (ALT) - instillation of high concentrations of anti-microbial agent with or without anti-coagulant into the lumen of central venous... 
permanent central venous catheter | catheter-related sepsis | antibiotic lock therapy | conservative management | BLOOD-STREAM INFECTION | MANAGEMENT | HOME-PARENTERAL-NUTRITION | INTRAVASCULAR DEVICES | CENTRAL VENOUS CATHETER | SEPSIS | MODEL | DAPTOMYCIN | STAPHYLOCOCCUS-EPIDERMIDIS | BACTEREMIA | PHARMACOLOGY & PHARMACY | Anti-Bacterial Agents - therapeutic use | Sterilization - methods | Catheter-Related Infections - etiology | Humans | Bacteremia - drug therapy | Catheterization, Central Venous | Anti-Bacterial Agents - administration & dosage | Catheter-Related Infections - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights